Nu Skin Executive Makes Bold Stock Purchase!
Nu Skin's Chief Product Officer, Steven Keith Hatchett, purchased 5,500 shares of the company's stock for $52,855, signaling confidence in its future. The company reported strong Q3 growth, particularly in Latin America, and launched the Prysm iO wellness platform. Despite challenges in North America, Nu Skin projects Q4 revenue between $365 million to $400 million. TipRanks' AI Analyst rates NUS as Neutral, highlighting strengths in emerging markets and product innovation, but notes risks from declining revenue and bearish technical indicators.
New insider activity at Nu Skin ( (NUS) ) has taken place on November 12, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Nu Skin’s Chief Product Officer, Steven Keith Hatchett, has made a significant investment by purchasing 5,500 shares of the company’s stock. This transaction is valued at $52,855, reflecting a strong vote of confidence in the company’s future prospects.
Recent Updates on NUS stock
Nu Skin Enterprises recently held its Q3 earnings call, highlighting robust growth in emerging markets and the launch of the Prysm iO wellness platform as key drivers of future growth. Despite challenges in North America and foreign currency impacts, the company reported strong performance in Latin America with a 53% year-over-year growth, and sequential growth in European and Asian markets. The introduction of Prysm iO, with plans to deploy over 10,000 units in Q4, is expected to be a major growth catalyst. Nu Skin’s gross margin improved to 70.5%, attributed to strategic portfolio optimization and product mix improvements. The company maintains a strong financial position with $252 million in cash and reduced debt, providing a solid foundation for future initiatives. However, macro environmental factors and changes in the business model continue to challenge the North American market. Looking ahead, Nu Skin projects Q4 revenue between $365 million to $400 million and full-year revenue guidance of $1.48 billion to $1.51 billion, reflecting cautious optimism and strategic focus on key growth areas.
Spark’s Take on NUS Stock
According to Spark, TipRanks’ AI Analyst, NUS is a Neutral.
Nu Skin’s overall stock score reflects a balance of positive strategic initiatives and attractive valuation against financial and technical challenges. The promising growth in emerging markets and innovative product launches are significant strengths, while declining revenue and bearish technical indicators are key risks.
To see Spark’s full report on NUS stock, click here.
More about Nu Skin
YTD Price Performance: 41.78%
Average Trading Volume: 549,097
Technical Sentiment Signal: Sell
Current Market Cap: $481.2M
